# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Evercore ISI Group analyst Elizabeth Anderson maintains Dentsply Sirona (NASDAQ:XRAY) with a Outperform and lowers the price...
Barrington Research analyst Michael Petusky maintains Dentsply Sirona (NASDAQ:XRAY) with a Outperform and lowers the price t...
Piper Sandler analyst Jason Bednar reiterates Dentsply Sirona (NASDAQ:XRAY) with a Neutral and lowers the price target from ...
Baird analyst Jeffrey Johnson maintains Dentsply Sirona (NASDAQ:XRAY) with a Neutral and lowers the price target from $35 to...
Needham analyst David Saxon maintains Dentsply Sirona (NASDAQ:XRAY) with a Buy and lowers the price target from $42 to $36.
Dentsply Sirona's Q1 disappoints with revenue miss at $953M, down 2.6% YoY; adjusted EPS meets expectations at 42 cents.
The Company is maintaining its 2024 outlook for organic sales growth in the range of flat to up 1.5%, and adjusted EPS in the r...